MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Brian, C. A.
Right arrow Articles by Ward, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Brian, C. A.
Right arrow Articles by Ward, N. E.

ATP-sensitive binding of melittin to the catalytic domain of protein kinase C

CA O'Brian and NE Ward

Department of Cell Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030.

Protein kinase C (PKC) is a Ca2+- and phospholipid-dependent protein kinase that appears to play a critical role in the regulation of cell growth. Melittin was previously shown to inhibit Ca2+- and phosphatidylserine (PS)-dependent PKC activity with an inhibitory potency that was reduced as the PS concentration was elevated. In this report, we found that melittin could inhibit activation of PKC by Ca2+ and PS, with an IC50 of 3 microM. When the enzyme activity was released from regulation by Ca2+ and PS by the generation of an active catalytic fragment of PKC through limited proteolysis, melittin inhibited the enzyme activity with an IC50 of 25 microM. Through inhibitor binding studies and enzyme kinetics, we established that melittin binds directly to the catalytic domain of PKC and that the substrate MgATP can release bound melittin from PKC. Melittin bound to PKC in the absence of PKC cofactors, and MgATP completely disrupted the binding of melittin to PKC, whereas phosphoacceptor substrates did not. The catalytic fragment of PKC, which contains two potential ATP-binding sites according to sequence analysis of PKC-encoding cDNAs, also bound melittin. The kinetics of inhibition of the catalytic fragment were consistent with a noncompetitive inhibition with respect to the substrate ATP, providing evidence that the antagonism of the binding of melittin to PKC by MgATP is not due to a direct competition between MgATP and melittin at the active site of PKC.

Volume 36, Issue 3, pp. 355-359, 09/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. E. Ward, K. R. Gravitt, and C. A. O'Brian
Covalent Modification of Protein Kinase C Isozymes by the Inactivating Peptide Substrate Analog N-Biotinyl-Arg-Arg-Arg-Cys-Leu-Arg-Arg-Leu. EVIDENCE THAT THE BIOTINYLATED PEPTIDE IS AN ACTIVE-SITE AFFINITY LABEL
J. Biol. Chem., September 27, 1996; 271(39): 24193 - 24200.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. E. Ward, K. R. Gravitt, and C. A. O'Brian
Irreversible Inactivation of Protein Kinase C by a Peptide-Substrate Analog
J. Biol. Chem., April 7, 1995; 270(14): 8056 - 8060.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics